Induction of interferon-fl (IFN-fl) in human (BG-9), simian (CV-1) and mouse (L-929) cell lines by Sendai virus and by poly(rI), poly(rC) has been studied for its possible dependence on protein kinase C (PKC) through the use of pharmacological inhibitors (K252a and H-7) of PKC. Exposure of BG-9, CV-1 or L-929 cells to K252a (>10.025 ~tM), a staurosporine derivative, 24 h before or after induction of IFN with poly(rl).poly(rC), inhibited by > 95 % the production of IFN-fl. In contrast, virus-induced 1FN production was enhanced threefold or more by K252a in BG-9 and L-929 but not in CV-1 cells. A naphthalene sulphonamide inhibitor of PKC, H-7, at >/5 ~tM, decreased poly(rI).poly(rC)-induced IFN production in BG-9 and CV-1 cells by 75 to 94%, but had no effect on IFN production in L-929 cells. Viral induction of IFN was not affected significantly by H-7 in BG-9, CV-1 and L-929 cells. In contrast to these results, the calmodulin inhibitor, trifluoperazine (5 to 15 ~tM) did not affect IFN-fl production by poly(rI).poly(rC) but significantly enhanced IFN production by Sendai virus in both human and murine cell lines. Thus, in human and simian fibroblasts the induction of IFN-fl by poly(rI).poly(rC) appears to be PKC-dependent, whereas viral induction of IFN-fl is not. Results with K252a implicate PKC in non-viral induction of IFN in mouse fibroblasts, as well. Direct measurements of PKC activity in BG-9 cells exposed to several concentrations of K252a showed that the membrane PKC activity is significantly more sensitive to inhibition by K252a than is cytosolic PKC activity. In L-929 cells, K252a inhibited membrane PKC activity similarly, but was less effective as an inhibitor of cytosolic enzyme activity than in BG-9. These studies support an intregral role for PKC activity, particularly membraneassociated activity, in non-viral [poly(rI).poly(rC)] induction of IFN-fl in human, simian and mouse fibroblasts.
Introduction
In recent years much attention has been devoted to molecular mechanisms that may regulate the interferonfl (IFN-fl) gene (Fujita et al., 1985; Zinn et al., 1983; Goodburn et al., 1985; Maroteaux et al., 1983) . Although the gene for IFN-fl has been cloned (Taniguchi et al., 1979) , and regulatory elements identified (Fujita et al., 1987 (Fujita et al., , 1989 Taniguchi, 1989) , the multi-step induction process starting from the interaction of the IFN inducer with the cell surface to the initiation of IFN gene transcription remains to be elucidated. Recent studies have suggested the importance of discrete 'second messengers' in the transmission of intracellular signals from the cell membrane to the nucleus in the IFN induction process. Two distinct classes of transduction signals in response to extracellular stimuli have been proposed: one involves the calcium~:almodulin-medicated cellular processes and the second is mediated via the diacylglycerol-protein kinase C pathway (Nishizuka, 1984; Rasmussen et al., 1984) .
We have recently described the role of calciumcalmodulin-mediated cellular processes in the induction of IFN-fl in human (Hu) and murine (Mu) cell cultures by Sendai virus . Others have suggested that the production of HulFN-~ may be less susceptible to modulation by calmodulin than HulFN-7 with poly-(rI). poly(rC) as an inducer (Cesario et al., 1988) . A role for dsRNA-dependent protein kinase has been suggested in the induction of IFN-fl (Marcus & Sekellick, 1988; Zinn et al., 1988) . Evidence for the latter, however, is based on the inhibition of IFN-fl induction by 2-aminopurine, without demonstration of a direct effect of the drug on dsRNA-dependent protein kinase or on cellular protein kinases. More recently, the role of protein kinase C (PKC) in the production of IFN-~ was suggested, based on the activation of cytosolic PKC in IFN-induced cells (Tamura-Nishimura & Sasakawa, 0000-9743 © 1990 SGM 1989 . In spite of the different IFN inducers and cell types used in the studies mentioned above, it appears that one or both of the intracellular signalling pathways may be operative in the IFN production process.
In this report we describe production of IFN-fl in the presence of pharmacological inhibitors of PKC in human, simian and murine cell cultures using viral and non-viral inducers. The results suggest that the intracellular signal pathways for IFN-fl induction are different for viral and non-viral inducers.
Methods
Cell cultures. Human foreskin (BG-9), African green monkey kidney (CV-1) and murine L-929 cells were grown and maintained in Eagle's MEM, as described previously Thacore et al., 1982) .
Viruses. Vesicular stomatitis virus (VSV, Indiana serotype) was grown and assayed for p.f.u, in L-929 cells (Winship & Thacore, 1979) . Sendai virus (Cantell strain) was grown in 10-day old embryonated chicken eggs and assayed for haemagglutinating units (HAU) using chicken erythrocytes (Thacore et al., 1985) .
Calmodulin and PKC inhibitors. Trifluoperazine (TFP) has been shown to be a potent calmodulin antagonist (Zimmer & Hofmann, 1987) . K252a, (8*R,9S*,llS*)-(-)hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11 -epoxy-1H,8 H, 11H-2,7b, 11 a-triazodibenzo(a,g)cycldocta(cde)trinden-l-one, is a microbial alkaloid inhibitor of PKC (Kase et al., 1986) . H-7 is a naphthalene sulphonamide derivative which inhibits PKC activity; the naphthalene ring is replaced by isoquinoline with the addition of 1-(5-isoquinolinylsulphonyl)-2-methyl-piperazine (Hidaka et al., 1984) . TFP and H-7 were purchased from Sigma, and K-252a from Calbiochem.
Cytosolic and membrane-associated protein kinase activity in cell cultures. Effects of a calmodulin antagonist (TFP) and PKC inhibitors (K252a, H-7) on cellular PKC activity were determined as follows. Cell monolayers were treated with various concentrations of TFP (5 to 15 ktM), K252a (0.01 to 0.1 ktM) or H-7 (5 to 25 laM) for 24 h at 37 °C. The cultures were washed with phosphate-buffered saline (PBS), pH 7.4, trypsinized and the cells were transferred to Eppendorf tubes. The cells were centrifuged in a microfuge and washed twice with PBS. The pellet was resuspended in 10 mM-Tris-HCl pH 7.4 containing 0.1 mM-EGTA, 5 mM-mercaptoethanol and 0.01% leupeptin. The cell lysate was centrifuged and the supernatant collected and assayed for cytosolic PKC activity. The pellet was resuspended in buffer and assayed for membrane-associated PKC activity.
PKC activity was measured as described previously (Lawrence et al., 1989) . In short, the cytosol or membrane preparations were incubated in 25 mM-Tris-HC1 pH 7.4, 6.25 mM-magnesium acetate, 0"25 mM-EGTA, 25 ~tg/ml phosphatidyl serine, 1 ~tg/ml dioleacyl glycerol, 200 ~tg/ml histone, 0.50 mM-CaC12 and 10 p.M-ATP with 0-25 pCi of [y-32P]ATP and incubated for 5 min at 30 °C. The reaction was stopped by adding TCA. The acid precipitate was filtered through a Millipore MiUititer filtration device using 0-45 ~tm-nitrocellulose filters and radioactivity was determined in a scintillation counter. PKC activity was expressed as pmol Pi/mg protein/rain.
Effect of PKC inhibitors on IFN induction by viral and non-viral inducers.
Confluent monolayers of human, simian or murine cells (1 x 10S/well) were grown in 24-well trays and treated with the appropriate drug for 24 h at 37 °C. Control cells received medium for 24 h at 37 °C. It should be noted that drug toxicity studies were conducted in each cell type using the trypan blue exclusion method to determine the appropriate non-toxic concentration of drug to be used. IFN was induced in treated and control cultures by infecting with Sendai virus (50 HAU/well) or by exposure to 0.1 ktg of poly(rl), poly-(rC) with 100 ~tg DEAE-dextran . After an adsorption period of 1 h at 37 °C, monolayers were washed twice with warm medium, refed with medium or medium containing the appropriate concentration of the drug and reincubated at 37 °C. At 24 h after IFN induction, culture fluid was harvested and treated at pH 2-0 at 4 °C for 48 h prior to assay for IFN activity in homologous cells as described below.
IFN assay. The antiviral activity of human and simian IFNs was assayed in BG-9 cell cultures by the semi-microassay using VSV as the challenge virus as described previously (Thacore et al., 1985) . Simian IFN was assayed in BG-9 cells and not in homologous CV-1 cells because CV-1 cells are 85-fold less sensitive than BG-9 cells to the antiviral action of human or simian IFNs (H. R. Thacore, unpublished observations). The HulFN<t (International Standard 69/19) obtained from the MRC, U.K. was used as a reference when assaying for antiviral activity on BG-9 cells. The MulFN activity is expressed as laboratory units (LU).
Quantification of lFN-fl mRNA in IFN-induced cell cultures.
IFN was induced in cell cultures by poly(rI), poly(rC) in the presence or absence of the drug as described above. At appropriate intervals, RNA was extracted using the single-step acid guanidinium thiocyanate-phenolchloroform extraction procedure of Chomczynski & Sacchi (1987) . IFN-fl mRNA was quantified by the dot blot procedure as described previously (Hudecki et al., 1986 ) using plasmid Tp IF319 containing a cDNA insert of 600 bp specific for HulFN-fl (Taniguchi et al., 1980) . The plasmid was obtained from Dr Tadatsugu Taniguchi, Japanese Foundation for Cancer Research, Tokyo, Japan.
Results

Effect of PKC inhibitors on IFN production by poly(rl) .poly(rC) and Sendai virus in cell cultures
To examine the effect of K252a on IFN production by poly(rI).poly(rC) and Sendai virus, cells were treated with various concentrations of the drug prior to and or during induction and assayed for IFN activity as described in Methods. The results presented in Table 1 show that in human, simian and murine ceils the production of IFN by poly(rI).poly(rC) was markedly inhibited in cells treated with K252a prior to or during induction. The inhibition was however more pronounced in human cells than in simian and murine cell systems. The inhibition in human and murine cell systems was correlated with the relative sensitivity of the PKC activity to K252a (Table 2 ). For example, 0.050 pMK252a inhibited cytosolic and membrane-associated PKC activity in human cells by 100 and 89%, respectively. In contrast, in murine cells, 0.050 and 0.100 lxM-K252a inhibited cytosolic and membrane-associated PKC activity on average by only 27 and 41%, respectively (Table 2) . It is interesting to note that pretreatment of human cells with 0.01 or 0.025 ~tM-K252a, which inhibited membrane-associated PKC activity by 60 and 85 ~, respectively, without significantly affecting cytosolic PKC activity, also inhibited the production of IFN by poly(rI), poly(rC) (see Table 1 ). These results suggest that membrane-associated PKC activity plays an important role in the production of IFN by poly(rI), poly(rC). In contrast, under similar experimental conditions, Sendai virus-induced IFN production was enhanced in human and murine cells three-to sixfold whereas no significant difference was noted in CV-1 cells (Table 1) . Similar enhancement of IFN production has been reported by us previously in TFP-treated cells (Linet al., 1990) . It should however be noted that the enhancement of IFN production in the presence of TFP in human and murine cells was 16-and 32-fold respectively, significantly greater than that observed in the presence of K252a. Similar experiments were also conducted with another PKC inhibitor, H-7. Results presented in Table 3 show that in human and simian cells, the inhibition by H-7 of IFN production by poly(rI), poly(rC) ranged from 75 to 94~, whereas no effect on IFN production was observed in murine cells. It should be noted that no significant difference was observed in the sensitivity of human and murine cells to H-7 with respect to inhibition of cytosolic and membrane-associated PKC activity (data not shown). These results suggest that in L-929 cells, the induction of IFN by poly(rI), poly(rC) may depend on a pathway other than that involving PKC. No significant effect of H-7 was observed on IFN production by Sendai virus in all three cell systems (Table 3) .
Effect of varying the time of treatment with K252a on IFN production by poly(rI).poly(rC)
In the experiments described above, the appropriate drug was added either 24 h prior to or 1 h after IFN induction. The following experiment was conducted to determine whether K252a can exert its effect in cells actively producing IFN. IFN was induced in human cells by poly(rI), poly(rC) in the usual manner and at various times after induction, medium was Fig. 1 show that addition of K252a at 2 h after induction resulted in complete inhibition (undetectable amount) of IFN production. Addition of K252a between 4 and 12 h after induction resulted in a six-and 16-fold decrease in IFN production as compared to control untreated cultures (Fig. 1) . The small but significant amount of IFN produced in cultures which received K252a between 4 and 12 h after induction may be due to reduced transcription or translation of the IFN-fl gene.
To choose between these two possibilities, we determined the relative amounts of IFN-fl mRNA in poly(rI).poly(rC)-induced cells in the presence and absence of K252a. An experiment similar to that described in Fig. 1 was conducted except K252a was added at the time of induction (0 h) and at 2 and 4 h induction with poly(rI), poly(rC). The cells were harvested at 24 h, total RNA was extracted and the amount of IFN-fl mRNA determined by dot blot hybridization using an IFN-fl cDNA probe as described in Methods. The results presented in Fig. 2 show that when K252a was added at the time of induction with poly(rI).poly-(rC), no IFN-fl mRNA was detected at 24 h after induction. In contrast, when K252a was added at 2 or 4 h after induction with poly(rI).poly(rC), IFN-fl mRNA was detected in cells at 24 h after induction. The abundance of IFN-fl mRNA in cells treated with K252a at 4 h after induction was not significantly different from IFN-fl mRNA synthesized in cultures in the absence of the drug (Fig. 2) . Based on the data presented in Fig. 1 and 2, it can be concluded that in cells actively producing IFN, the addition of K252a prevents IFN production by affecting the translation of IFN-fl mRNA.
Effect of calmodulin antagonist on IFN production by poly(r I ) . poly(rC )
Based on the results of our previous ) and the present studies (Tables 1 and 3) , it can be concluded that different induction pathways exist for IFN production according to the inducing agent: virus induction occurs via the calcium/calmodulin pathway and poly(rI). poly(rC) induction depends upon PKC mediation. To rule out the involvement of calcium/calmodulin pathway in IFN production by poly(rI).poly(rC), the effect of TFP on IFN production by poly(rI).poly(rC) was investigated. Cell cultures were treated with various concentrations of TFP prior to and/or during induction and assayed for IFN production as described in Methods. Sendai virus was included in the experiment as a control. The results presented in Table 4 show that the induction of IFN by poly(rI), poly(rC) was not affected by TFP in both human and murine cells. In contrast, the production of IFN by Sendai virus in both human and murine cells was significantly enhanced by TFP, confirming our previous results . It should be noted that the concentrations of TFP used in the experiments had no significant effect on cytosolic PKC activity, but significantly enhanced membraneassociated PKC activity in both human and murine cells (data not shown). These results suggest that calmodulinmediated cellular processes are not involved in the induction of IFN by poly(rI), poly(rC) in these cell types.
D i s c u s s i o n
In this study we present evidence that viral and non-viral inducers of IFN-fl production depend on discrete second messenger mechanisms. IFN production after treatment with the non-viral inducer poly(rI), poly(rC) was inhibited by specific pharmacological inhibitors of PKC activity (Tables 1 and 3) . In human cells, the inhibitory effect of K252a, when added simultaneously with poly(rI), poly(rC), was attributed to the lack of IFN-fl mRNA synthesis (Fig. 2) . Similar conclusions were also reached by Sehgal et al. (1987) using diacylglycerol as an enhancer of IFN-fl2 mRNA synthesis in human cells. However when K252a was added at 4 h after induction, the amount of biologically active IFN produced was significantly reduced in K252a-treated cells ( Fig. 1 and  2 ), although the abundance of IFN-fl mRNA in these cells at 24 h after induction was not significantly different from control induced cells. These results Interferon-fl mRNA synthesis in human cells in the presence and absence of K252a. IFN was induced in BG-9 cells with poly(rI), poly(rC) and at 0, 2 and 4 h after induction appropriate cultures were exposed to 0-10 ~tM-K252a and reincubated at 37 °C. After 24 h cells were harvested for RNA extraction as described in Methods. An equal amount of RNA from each sample was serially diluted twofold (from left to right), blotted onto nitrocellulose paper, hybridized with radiolabelled IFN-fl cDNA and developed and photographed as an autoradiogram as described in Methods. suggest that K252a may also exert its effect at the translational level. The role of PKC in regulation of protein biosynthesis in eukaryotic cells is well documented. From the results of our present study and those of other reports (Sehgal et al., 1987; Gessani et al., 1989) , it is likely that PKC activity is involved in the induction of IFN-fl by poly(rI), poly(rC). Furthermore data presented in Table 4 show also that calcium--calmodulin-mediated cellular processes are not involved in IFN-fl production by poly(rI), poly(rC).
In contrast to non-viral IFN induction, IFN-fl production in response to Sendai virus in human, simian and murine cells was unaffected by H-7 (Table 3) , but enhanced in human and murine cells three-to sixfold by K252a (Table 1 ). The reason for the lack of enhancement of IFN-fl production by Sendai virus in CV-1 cells in the presence of K252a is not known. In addition, the calmodulin antagonist, TFP, significantly enhanced IFN production by Sendai virus in human and murine cells (Table 4 ; without affecting IFN production by poly(rI), poly(rC). Thus poly(rI), poly(rC) induction of IFN-fl requires activation of PKC, but does not involve calmodulin. In contrast, enhanced IFN production by Sendai virus necessitates inhibition of calmodulin action(s). IFN-fl mRNA quantification in experiments involving K252a suggests that the role of PKC in IFN induction is at the level of gene transcription, rather than at mRNA stabilization, since addition of the protein kinase inhibitor at the time of induction completely inhibits the expression of IFN-fl mRNA (Fig.2) . However, in cells already induced to make IFN-fl 4 h after induction, K252a reduced the amount of biologically active IFN produced without affecting the abundance of IFN mRNA, showing that kinase activity is also involved in mRNA translation. It is not surprising that there were differences in the patterns of the human and mouse cell responses to inhibitors of PKC since the effects of these inhibitors may be cell system-specific (human vs. mouse) (Sako et al., 1988) .
Because a substantial portion of these studies depended upon the use of pharmacological inhibitors of calmodulin action or of protein kinase activity, it is essential to consider the specificity of these antagonists. K252a and H-7 may inhibit kinase activities other than that of PKC, for example cAMP-and cGMP-dependent kinases (Kase et al., 1987; Hidaka et al., 1984) , at the concentrations employed in our studies. However we measured PKC activity in cytosol and in the membrane fraction of BG-9 and L-929 cells and demonstrated that concentrations of K252a at 0.01 to 0-10 I-tM indeed inhibited PKC activity. Our observations with K252a and H-7, together with results from other laboratories utilizing activators of PKC (Gessani et al., 1989; Sehgal et al., 1987) , strongly support a regulatory role for this kinase in the induction by poly(rI), poly(rC) of IFN-fl. The possibility that kinase activity other than that of PKC is involved in IFN-fl induction by poly(rI), poly-(rC) is not excluded in the present studies. What is clear is that Sendal virus and poly(rI), poly(rC) depend upon discrete mechanisms for their induction of IFN. Attempts to identify the membrane protein substrate(s) phosphorylated by kinase activity during IFN induction are in progress.
